SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-020321
Filing Date
2022-05-24
Accepted
2022-05-23 20:51:49
Documents
18
Period of Report
2022-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20004305x1_8k.htm   iXBRL 8-K 55208
2 EXHIBIT 2.1 ny20004305x1_ex2-1.htm EX-2.1 461636
3 EXHIBIT 10.1 ny20004305x1_ex10-1.htm EX-10.1 40798
4 EXHIBIT 99.1 ny20004305x1_ex99-1.htm EX-99.1 85083
5 EXHIBIT 99.2 ny20004305x1_ex99-2.htm EX-99.2 86015
6 EXHIBIT 99.3 ny20004305x1_ex99-3.htm EX-99.3 26808
10 image2.jpg GRAPHIC 1091
  Complete submission text file 0001140361-22-020321.txt   1055524

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA inva-20220523.xsd EX-101.SCH 3911
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220523_lab.xml EX-101.LAB 22544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220523_pre.xml EX-101.PRE 16034
12 EXTRACTED XBRL INSTANCE DOCUMENT ny20004305x1_8k_htm.xml XML 4226
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 22953623
SIC: 2834 Pharmaceutical Preparations